Accuray
Accuray makes the CyberKnife robotic radiosurgery system and the TomoTherapy and Radixact helical radiotherapy platforms, and sponsors trials of stereotactic and adaptive radiotherapy.
Overview
Accuray, listed on Nasdaq and headquartered in Madison, Wisconsin after moving from Sunnyvale, California, manufactures radiotherapy equipment: the CyberKnife, a linear accelerator on a robotic arm that tracks tumour motion for stereotactic radiosurgery and stereotactic body radiotherapy, and the TomoTherapy and Radixact systems, which deliver helical intensity-modulated radiotherapy with daily imaging. It sponsors clinical trials of hypofractionated and adaptive treatment on its platforms. It appears on OnCo as a lead sponsor of phase 3 cancer trials on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- InstitutionMount Vernon Cancer Centre
Shares Hypofractionation (fewer, larger radiotherapy doses), Radiotherapy.
- PersonDavid A. Palma
Shares Radiotherapy, SBRT / SABR (stereotactic radiotherapy).
- TermStereotactic body radiotherapy (SBRT / SABR)
Shares Hypofractionation (fewer, larger radiotherapy doses), SBRT / SABR (stereotactic radiotherapy).
- TermSystemic versus local therapy
Shares Radiotherapy, SBRT / SABR (stereotactic radiotherapy).
- TermAbscopal effect
Shares Radiotherapy, SBRT / SABR (stereotactic radiotherapy).